Literature DB >> 31512778

The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer.

Atena Soleimani1, Farzad Rahmani1, Nikoo Saeedi2, Rana Ghaffarian2, Majid Khazaei3,4, Gordon A Ferns5, Amir Avan3,6, Seyed Mahdi Hassanian1,3.   

Abstract

Colorectal cancer (CRC) is the leading cause of cancer death worldwide. Dysregulation of RAS/MAPK signaling axis is frequently found in CRC patients. The RAS/MAPK axis regulates cancer cell proliferation, apoptosis, inflammation, migration, and metastasis. Oncogenic or tumor-suppressor microRNAs (miRNAs) for RAS/MAPK signaling play a key role in the pathogenesis of CRC and are considered as novel potential biomarkers for diagnosis and prognosis of human malignancies. This review summarizes the current knowledge of mechanisms of action of RAS/MAPK miRNAs in the development and progression of CRC for a better understanding and hence a better management of this disease.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  RAS/MAPK signaling; colorectal cancer; microRNA

Year:  2019        PMID: 31512778     DOI: 10.1002/jcb.29268

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  Identification of key candidate genes and pathways associated with colorectal aberrant crypt foci-to-adenoma-to-carcinoma progression.

Authors:  Setareh Fayazfar; Afsaneh Arefi Oskouie; Akram Safaei; Hakimeh Zali; Ehsan Nazemalhosseini Mojarad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

2.  Molecular Targets and Mechanisms of Hedyotis diffusa-Scutellaria barbata Herb Pair for the Treatment of Colorectal Cancer Based on Network Pharmacology and Molecular Docking.

Authors:  Zhenpeng Yang; Shuai Lu; Huazhen Tang; Jinxiu Qu; Bing Wang; Yuying Wang; Guofeng Pan; Benqiang Rao
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-06       Impact factor: 2.650

3.  Oncogenic Landscape of Somatic Mutations Perturbing Pan-Cancer lncRNA-ceRNA Regulation.

Authors:  Yuanfu Zhang; Peng Han; Qiuyan Guo; Yangyang Hao; Yue Qi; Mengyu Xin; Yafang Zhang; Binbin Cui; Peng Wang
Journal:  Front Cell Dev Biol       Date:  2021-05-17

4.  Integrated characterization and validation of the prognostic significance of microRNA-200s in colorectal cancer.

Authors:  Qiliang Peng; Ming Cheng; Ting Li; Xiangying Chen; Yi Shen; Yaqun Zhu; Bo Xu
Journal:  Cancer Cell Int       Date:  2020-02-18       Impact factor: 5.722

Review 5.  Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways.

Authors:  Milad Ashrafizadeh; Hossein Rafiei; Reza Mohammadinejad; Tahereh Farkhondeh; Saeed Samarghandian
Journal:  Cancer Cell Int       Date:  2021-01-21       Impact factor: 5.722

6.  Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes.

Authors:  Shuting Wen; Long He; Zhuotai Zhong; Hong Mi; Fengbin Liu
Journal:  Front Mol Biosci       Date:  2020-11-27

7.  TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer.

Authors:  Guolin Zhang; Xin Luo; Zian Wang; Jianbin Xu; Wei Zhang; Engeng Chen; Qing Meng; Di Wang; Xuefeng Huang; Wei Zhou; Zhangfa Song
Journal:  Aging (Albany NY)       Date:  2022-01-12       Impact factor: 5.682

8.  Inhibition of lncRNA SNHG8 plays a protective role in hypoxia-ischemia-reoxygenation-induced myocardial injury by regulating miR-335 and RASA1 expression.

Authors:  Yanfeng Liu; Ping Zhou; Fengxiao Wang; Xuehong Zhang; Dongmei Yang; Lang Hong; Dongyun Ruan
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

9.  E2F4 functions as a tumour suppressor in acute myeloid leukaemia via inhibition of the MAPK signalling pathway by binding to EZH2.

Authors:  Yubin Feng; Lanlan Li; Yan Du; Xiaoqing Peng; Feihu Chen
Journal:  J Cell Mol Med       Date:  2020-01-14       Impact factor: 5.310

10.  MicroRNA-Related Prognosis Biomarkers from High-Throughput Sequencing Data of Colorectal Cancer.

Authors:  Xiao-Liang Xing; Zhi-Yong Yao; Ti Zhang; Ning Zhu; Yuan-Wu Liu; Jing Peng
Journal:  Biomed Res Int       Date:  2020-09-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.